Foundation, Celgene Partner on Pharmacogenomic Test
May 17, 2011
Foundation, Celgene Partner on Pharmacogenomic Test
Foundation's test will be used to hasten faster recruitment of target patient populations and for broad genetic characterization of trial enrollees to identify those most likely to respond to Celgene's drug candidates.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Foundation Medicine, Eisai Ink Personalized Med Alliance
October 9, 2012 / GenomeWeb Daily News - Foundation Medicine, Novartis Ink New Deal for Clinical Oncology Programs
June 7, 2012 / GenomeWeb Daily News - Foundation Medicine, AstraZeneca to ID Genetic Mutations for Cancer Drug Development
November 12, 2012 / GenomeWeb Daily News - At AACR, Foundation Medicine Reports Strong Demand for NGS-based Profiling to Guide Cancer Treatment
April 4, 2012 / Pharmacogenomics Reporter - Metamark Teams with Janssen on Prognostic Markers
December 20, 2011 / GenomeWeb Daily News